Robert e. Abernathy

Robert e. Abernathy, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Avient Corp and Haemonetics Corp. Over a trading history stretching from 30 June 2021 to 30 September 2026, the count stands at 28 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 2 October 2026 came the latest disclosure, a share grant in Avient Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.